Epizyme (EPZM) Tops Q4 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Epizyme (EPZM) Tops Q4 EPS by 5c

Epizyme (EPZM) PT Lowered to $19 at RBC Capital; Reiterates Outperform

March 9, 2017 1:20 PM EST

RBC Capital lowered its price target on Epizyme (NASDAQ: EPZM) to $19.00 (from $26.00) while maintaining a Outperform rating. Epizyme provided a development update and discussed its current understanding of tazemetostats mechanism of action .

Analyst Simos Simeonidis commented, "Epizyme provided a development update on... More